HEALTH TIPS.
Daily Health Fitness Tips
Wednesday, 30 September 2026
Oral small-molecule GLP-1 receptor agonist safiglipron in early type 2 diabetes: a randomized, double-blind, placebo-controlled trial | Nature Medicine
submitted by
/u/chilladipa
[link]
[comments]
from Health https://ift.tt/f1duqSM
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment